A novel intracellular peptide derived from G1/S cyclin D2 induces cell death

Journal of Biological Chemistry

Volumn 289, Issue 24, 2014, Pages 16711-16726

  De Araujo, Christiane B ^a   Russo, Lilian C ^a   Castro, Leandro M ^a   Forti, Fábio L ^a   Do Monte, Elisabete R ^a   Rioli, Vanessa ^b   Gozzo, Fabio C ^c   Colquhoun, Alison ^a   Ferro, Emer S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLATION; AMINO ACIDS; CELL DEATH; CHEMICAL ACTIVATION;

ACTIVE SEQUENCES; CASPASE-3/7; CELL-PENETRATING PEPTIDE; GLIOBLASTOMAS; INTRACELLULAR PEPTIDES; PROTEASOMES; TUMOR CELLS; UBIQUITIN-PROTEASOME SYSTEM;

PEPTIDES;

ALANINE; CASPASE 3; CASPASE 7; CASPASE 9; CELL PENETRATING PEPTIDE; CYCLIN D2; LEUCINE; PROTEIN KINASE B; SYNAPTOPHYSIN; TRYPTOPHAN; TRYPTOPHYLGLUTAMYLLEUCYLVALYLVALYLLEUCINE; TRYPTOPHYLGLUTAMYLLEUCYLVALYLVALYLLEUCYLGLYCYLLYSYLLEUCINE; UNCLASSIFIED DRUG;

ACETYLATION; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DEATH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG POTENCY; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; GLIOBLASTOMA; HUMAN; HUMAN CELL; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANTICANCER DRUG; APOPTOSIS; CELL CYCLE; CELL DEATH; NECROSIS (NECROTIC DEATH); PEPTIDES; PROTEASOME;

AMINO ACID CHLOROMETHYL KETONES; AMINO ACID MOTIFS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL CYCLE; CYCLIN D2; GLIOBLASTOMA; HELA CELLS; HUMANS; IMIDAZOLES; INDOLES; MALE; MALEIMIDES; MCF-7 CELLS; OLIGOPEPTIDES; QUINOLINES; RATS; RATS, WISTAR;

EID: 84902477335     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.537118     Document Type: Article

References (84)

1. Paz, P., Brouwenstijn, N., Perry, R., and Shastri, N. (1999) Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER. Immunity 11, 241-251 (Pubitemid 29428817)
2. Rock, K. L., and Goldberg, A. L. (1999) Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17, 739-779 (Pubitemid 29241139)
3. Hershko, A. (2005) The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle. Cell Death Differ. 12, 1191-1197
4. Goldberg, A. L. (2012) Development of proteasome inhibitors as research tools and cancer drugs. J. Cell Biol. 199, 583-588
5. Kisselev, A. F., Akopian, T. N., and Goldberg, A. L. (1998) Range of sizes of peptide products generated during degradation of different proteins by archaeal proteasomes. J. Biol. Chem. 273, 1982-1989 (Pubitemid 28069243)
6. Kisselev, A. F., Akopian, T. N., Woo, K. M., and Goldberg, A. L. (1999) The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation. J. Biol. Chem. 274, 3363-3371 (Pubitemid 29077173)
7. Rammensee, H. G. (2002) Survival of the fitters. Nature 419, 443-445
8. Geier, E., Pfeifer, G., Wilm, M., Lucchiari-Hartz, M., Baumeister, W., Eichmann, K., and Niedermann, G. (1999) A giant protease with potential to substitute for some functions of the proteasome. Science 283, 978-981
9. Suraweera, A., Münch, C., Hanssum, A., and Bertolotti, A. (2012) Failure of amino acid homeostasis causes cell death following proteasome inhibition. Mol. Cell 48, 242-253
10. Reits, E., Neijssen, J., Herberts, C., Benckhuijsen, W., Janssen, L., Drijfhout, J. W., and Neefjes, J. (2004) A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. Immunity 20, 495-506 (Pubitemid 38482126)
11. Reits, E., Griekspoor, A., Neijssen, J., Groothuis, T., Jalink, K., van Veelen, P., Janssen, H., Calafat, J., Drijfhout, J. W., and Neefjes, J. (2003) Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. Immunity 18, 97-108 (Pubitemid 36120691)
12. Beninga, J., Rock, K. L., and Goldberg, A. L. (1998) Interferon- can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase. J. Biol. Chem. 273, 18734-18742 (Pubitemid 28366257)
13. Kravtsova-Ivantsiv, Y., Cohen, S., and Ciechanover, A. (2009) Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-κB precursor. Mol. Cell 33, 496-504
14. Gelman, J. S., Dasgupta, S., Berezniuk, I., and Fricker, L. D. (2013) Analysis of peptides secreted from cultured mouse brain tissue. Biochim. Biophys. Acta 1834, 2408-2417
15. Fricker, L. D., Gelman, J. S., Castro, L. M., Gozzo, F. C., and Ferro, E. S. (2012) Peptidomic analysis of HEK293T cells: effect of the proteasome inhibitor epoxomicin on intracellular peptides. J. Proteome Res. 11, 1981-1990
16. Ferro, E. S., Hyslop, S., and Camargo, A. C. (2004) Intracellullar peptides as putative natural regulators of protein interactions. J. Neurochem. 91, 769-777 (Pubitemid 39507353)
17. Burns-Hamuro, L. L., Ma, Y., Kammerer, S., Reineke, U., Self, C., Cook, C., Olson, G. L., Cantor, C. R., Braun, A., and Taylor, S. S. (2003) Designing isoform-specific peptide disruptors of protein kinase A localization. Proc. Natl. Acad. Sci. U.S.A. 100, 4072-4077 (Pubitemid 36418159)
18. Churchill, E. N., Qvit, N., and Mochly-Rosen, D. (2009) Rationally designed peptide regulators of protein kinase C. Trends Endocrinol. Metab. 20, 25-33
19. Rioli, V., Gozzo, F. C., Heimann, A. S., Linardi, A., Krieger, J. E., Shida, C. S., Almeida, P. C., Hyslop, S., Eberlin, M. N., and Ferro, E. S. (2003) Novel natural peptide substrates for endopeptidase 24.15, neurolysin, and angiotensin-converting enzyme. J. Biol. Chem. 278, 8547-8555 (Pubitemid 36800608)
20. Heimann, A. S., Gomes, I., Dale, C. S., Pagano, R. L., Gupta, A., de Souza, L. L., Luchessi, A. D., Castro, L. M., Giorgi, R., Rioli, V., Ferro, E. S., and Devi, L. A. (2007) Hemopressin is an inverse agonist of CB1 cannabinoid receptors. Proc. Natl. Acad. Sci. U.S.A. 104, 20588-20593
21. Dodd, G. T., Mancini, G., Lutz, B., and Luckman, S. M. (2010) The peptide hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice. J. Neurosci. 30, 7369-7376
22. Gomes, I., Grushko, J. S., Golebiewska, U., Hoogendoorn, S., Gupta, A., Heimann, A. S., Ferro, E. S., Scarlata, S., Fricker, L. D., and Devi, L. A. (2009) Novel endogenous peptide agonists of cannabinoid receptors. FASEB J. 23, 3020-3029
23. Cunha, F. M., Berti, D. A., Ferreira, Z. S., Klitzke, C. F., Markus, R. P., and Ferro, E. S. (2008) Intracellular peptides as natural regulators of cell signaling. J. Biol. Chem. 283, 24448-24459
24. Berti, D. A., Morano, C., Russo, L. C., Castro, L. M., Cunha, F. M., Zhang, X., Sironi, J., Klitzke, C. F., Ferro, E. S., and Fricker, L. D. (2009) Analysis of intracellular substrates and products of thimet oligopeptidase in human embryonic kidney 293 cells. J. Biol. Chem. 284, 14105-14116
25. Russo, L. C., Castro, L. M., Gozzo, F. C., and Ferro, E. S. (2012) Inhibition of thimet oligopeptidase by siRNA alters specific intracellular peptides and potentiates isoproterenol signal transduction. FEBS Lett. 586, 3287-3292
26. Berti, D. A., Russo, L. C., Castro, L. M., Cruz, L., Gozzo, F. C., Heimann, J. C., Lima, F. B., Oliveira, A. C., Andreotti, S., Prada, P. O., Heimann, A. S., and Ferro, E. S. (2012) Identification of intracellular peptides in rat adipose tissue: insights into insulin resistance. Proteomics 12, 2668-2681
27. Russo, L. C., Asega, A. F., Castro, L. M., Negraes, P. D., Cruz, L., Gozzo, F. C., Ulrich, H., Camargo, A. C., Rioli, V., and Ferro, E. S. (2012) Natural intracellular peptides can modulate the interactions of mouse brain proteins and thimet oligopeptidase with 14-3-3∈ and calmodulin. Proteomics 12, 2641-2655
28. Che, F. Y., Biswas, R., and Fricker, L. D. (2005) Relative quantitation of peptides in wild-type and Cpe(fat/fat) mouse pituitary using stable isotopic tags and mass spectrometry. J. Mass Spectrom. 40, 227-237 (Pubitemid 40327262)
29. Morano, C., Zhang, X., and Fricker, L. D. (2008) Multiple isotopic labels for quantitative mass spectrometry. Anal. Chem. 80, 9298-9309
30. Zhang, R., Sioma, C. S., Thompson, R. A., Xiong, L., and Regnier, F. E. (2002) Controlling deuterium isotope effects in comparative proteomics. Anal. Chem. 74, 3662-3669 (Pubitemid 34855856)
31. Gallo, C. J., Koza, R. A., and Herbst, E. J. (1986) Polyamines and HeLa-cell DNA replication. Biochem. J. 238, 37-42 (Pubitemid 16024977)
32. Zhou, J. Y., Ma, W. L., Liang, S., Zeng, Y., Shi, R., Yu, H. L., Xiao, W. W., and Zheng, W. L. (2009) Analysis of microRNA expression profiles during the cell cycle in synchronized HeLa cells. BMB Rep. 42, 593-598
33. Benda, P., Lightbody, J., Sato, G., Levine, L., and Sweet, W. (1968) Differentiated rat glial cell strain in tissue culture. Science 161, 370-371
34. Udenfriend, S., Stein, S., Böhlen, P., Dairman, W., Leimgruber, W., and Weigele, M. (1972) Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science 178, 871-872
35. Castro, L. M., Berti, D. A., Russo, L. C., Coelho, V., Gozzo, F. C., Oliveira, V., and Ferro, E. S. (2010) Similar intracellular peptide profile of TAP1/β2 microglobulin double-knockout mice and C57BL/6 wild-type mice as revealed by peptidomic analysis. AAPS J. 12, 608-616
36. Che, F. Y., Zhang, X., Berezniuk, I., Callaway, M., Lim, J., and Fricker, L. D. (2007) Optimization of neuropeptide extraction from the mouse hypothalamus. J. Proteome Res. 6, 4667-4676
37. Wardman, J., and Fricker, L. D. (2011) Quantitative peptidomics of mice lacking peptide-processing enzymes. Methods Mol. Biol. 768, 307-323
38. Wang, G., Sun, W., Luo, Y., and Fang, N. (2010) Resolving rotational motions of nano-objects in engineered environments and live cells with gold nanorods and differential interference contrast microscopy. J. Am. Chem. Soc. 132, 16417-16422
39. Ziegler, A., Nervi, P., Dürrenberger, M., and Seelig, J. (2005) The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence. Biochemistry 44, 138-148 (Pubitemid 40095715)
40. Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., and Rothbard, J. B. (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. U.S.A. 97, 13003-13008
41. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254
42. Zarubin, T., and Han, J. (2005) Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15, 11-18 (Pubitemid 41653958)
43. Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., and Yuan, J. (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 1, 112-119
44. Caserta, T. M., Smith, A. N., Gultice, A. D., Reedy, M. A., and Brown, T. L. (2003) Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties. Apoptosis 8, 345-352 (Pubitemid 36935206)
45. Cuenda, A., Rouse, J., Doza, Y. N., Meier, R., Cohen, P., Gallagher, T. F., Young, P. R., and Lee, J. C. (1995) SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364, 229-233
46. Lali, F. V., Hunt, A. E., Turner, S. J., and Foxwell, B. M. (2000) The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase. J. Biol. Chem. 275, 7395-7402 (Pubitemid 30146294)
47. Sodeoka, M., and Dodo, K. (2010) Development of selective inhibitors of necrosis. Chem. Rec. 10, 308-314
48. Gelman, J. S., Sironi, J., Berezniuk, I., Dasgupta, S., Castro, L. M., Gozzo, F. C., Ferro, E. S., and Fricker, L. D. (2013) Alterations of the intracellular peptidome in response to the proteasome inhibitor bortezomib. PLoS One 8, e53263
49. Dodo, K., Katoh, M., Shimizu, T., Takahashi, M., and Sodeoka, M. (2005) Inhibition of hydrogen peroxide-induced necrotic cell death with 3-amino-2-indolylmaleimide derivatives. Bioorg. Med. Chem. Lett. 15, 3114-3118 (Pubitemid 40755206)
50. Wang, X., Ryter, S. W., Dai, C., Tang, Z. L., Watkins, S. C., Yin, X. M., Song, R., and Choi, A. M. (2003) Necrotic cell death in response to oxidant stress involves the activation of the apoptogenic caspase-8/bid pathway. J. Biol. Chem. 278, 29184-29191 (Pubitemid 36935834)
51. Ryter, S. W., Kim, H. P., Hoetzel, A., Park, J. W., Nakahira, K., Wang, X., and Choi, A. M. (2007) Mechanisms of cell death in oxidative stress. Antioxid. Redox Signal. 9, 49-89 (Pubitemid 44901874)
52. Kitanaka, C., and Kuchino, Y. (1999) Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ. 6, 508-515 (Pubitemid 29292106)
53. Hengartner, M. O. (2000) The biochemistry of apoptosis. Nature 407, 770-776
54. Jin, Z., and El-Deiry, W. S. (2005) Overview of cell death signaling pathways. Cancer Biol. Ther. 4, 139-163 (Pubitemid 41351311)
55. Peter, M. E., and Krammer, P. H. (2003) The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 10, 26-35 (Pubitemid 36511830)
56. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., and Wang, X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489 (Pubitemid 27508237)
57. Koseoglu, S., Lu, Z., Kumar, C., Kirschmeier, P., and Zou, J. (2007) AKT1, AKT2 and AKT3-dependent cell survival is cell line-specific and knockdown of all three isoforms selectively induces apoptosis in 20 human tumor cell lines. Cancer Biol. Ther. 6, 755-762 (Pubitemid 47328358)
58. Shen, Y. H., Zhang, L., Ren, P., Nguyen, M. T., Zou, S., Wu, D., Wang, X. L., Coselli, J. S., and LeMaire, S. A. (2013) AKT2 confers protection against aortic aneurysms and dissections. Circ. Res. 112, 618-632
59. Arboleda, M. J., Lyons, J. F., Kabbinavar, F. F., Bray, M. R., Snow, B. E., Ayala, R., Danino, M., Karlan, B. Y., and Slamon, D. J. (2003) Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of β1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res. 63, 196-206 (Pubitemid 36070440)
60. Lee, M. W., Kim, D. S., Lee, J. H., Lee, B. S., Lee, S. H., Jung, H. L., Sung, K. W., Kim, H. T., Yoo, K. H., and Koo, H. H. (2011) Roles of AKT1 and AKT2 in non-small cell lung cancer cell survival, growth, and migration. Cancer Sci. 102, 1822-1828
61. Conrad, P. W., Freeman, T. L., Beitner-Johnson, D., and Millhorn, D. E. (1999) EPAS1 trans-activation during hypoxia requires p42/p44 MAPK. J. Biol. Chem. 274, 33709-33713 (Pubitemid 129511686)
62. Wang, X., McGowan, C. H., Zhao, M., He, L., Downey, J. S., Fearns, C., Wang, Y., Huang, S., and Han, J. (2000) Involvement of the MKK6-p38 cascade in γ-radiation-induced cell cycle arrest. Mol. Cell Biol. 20, 4543-4552 (Pubitemid 30396102)
63. 2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 411, 102-107
64. Ferguson, S., and Lesniak, M. S. (2007) Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors. Curr. Drug Deliv. 4, 169-180 (Pubitemid 46557493)
65. Wen, P. Y., Kesari, S., and Drappatz, J. (2006) Malignant gliomas: strategies to increase the effectiveness of targeted molecular treatment. Expert Rev. Anticancer Ther. 6, 733-754 (Pubitemid 44192889)
66. Jiang, H., Alonso, M. M., Gomez-Manzano, C., Piao, Y., and Fueyo, J. (2006) Oncolytic viruses and DNA-repair machinery: overcoming chemoresistance of gliomas. Expert Rev. Anticancer Ther. 6, 1585-1592 (Pubitemid 44883961)
67. Kim, L., and Glantz, M. (2006) Chemotherapeutic options for primary brain tumors. Curr. Treat. Options Oncol. 7, 467-478 (Pubitemid 44697784)
68. Hershko, A. (1997) Roles of ubiquitin-mediated proteolysis in cell cycle control. Curr. Opin. Cell Biol. 9, 788-799
69. Chun, K. T., Mathias, N., and Goebl, M. G. (1996) Ubiquitin-dependent proteolysis and cell cycle control in yeast. Prog. Cell Cycle Res. 2, 115-127
70. Murray, R. Z., and Norbury, C. (2000) Proteasome inhibitors as anti-cancer agents. Anticancer Drugs 11, 407-417
71. Spataro, V., Norbury, C., and Harris, A. L. (1998) The ubiquitin-proteasome pathway in cancer. Br. J. Cancer 77, 448-455 (Pubitemid 28044050)
72. Karin, M., Cao, Y., Greten, F. R., and Li, Z. W. (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2, 301-310 (Pubitemid 37328783)
73. Glotzer, M., Murray, A. W., and Kirschner, M. W. (1991) Cyclin is degraded by the ubiquitin pathway. Nature 349, 132-138 (Pubitemid 21912025)
74. 1 phase progression: cycling on cue. Cell 79, 551-555
75. King, R. W., Jackson, P. K., and Kirschner, M. W. (1994) Mitosis in transition. Cell 79, 563-571 (Pubitemid 24363800)
76. Nurse, P. (1994) Ordering S phase and M phase in the cell cycle. Cell 79, 547-550
77. Nakayama, K. (1998) Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development. BioEssays 20, 1020-1029
78. Imajoh-Ohmi, S., Kawaguchi, T., Sugiyama, S., Tanaka, K., Omura, S., and Kikuchi, H. (1995) Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells. Biochem. Biophys. Res. Commun. 217, 1070-1077
79. Adams, J., Palombella, V. J., Sausville, E. A., Johnson, J., Destree, A., Lazarus, D. D., Maas, J., Pien, C. S., Prakash, S., and Elliott, P. J. (1999) Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res. 59, 2615-2622 (Pubitemid 29269108)
80. Drexler, H. C. (1997) Activation of the cell death program by inhibition of proteasome function. Proc. Natl. Acad. Sci. U.S.A. 94, 855-860
81. Sunwoo, J. B., Chen, Z., Dong, G., Yeh, N., Crowl Bancroft, C., Sausville, E., Adams, J., Elliott, P., and Van Waes, C. (2001) Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-κB, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. Clin. Cancer Res. 7, 1419-1428 (Pubitemid 32708698)
82. Chen, B. B., Glasser, J. R., Coon, T. A., Zou, C., Miller, H. L., Fenton, M., McDyer, J. F., Boyiadzis, M., and Mallampalli, R. K. (2012) F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation. Blood 119, 3132-3141
83. Haynes, C. M., Yang, Y., Blais, S. P., Neubert, T. A., and Ron, D. (2010) The matrix peptide exporter HAF-1 signals a mitochondrial UPR by activating the transcription factor ZC376.7 in C. elegans. Mol. Cell 37, 529-540
84. Ferro, E. S., Rioli, V., Castro, L. M., and Fricker, L. D. (2014) Intracellular peptides: from discovery to function. EuPA Open Proteomics 3, 143-151